Mediplantex National Pharmaceutical (MED) Stock Overview
Produces and trades in pharmaceutical products in Vietnam and internationally. More details
| Snowflake Score | |
|---|---|
| Valuation | 1/6 |
| Future Growth | 0/6 |
| Past Performance | 4/6 |
| Financial Health | 6/6 |
| Dividends | 1/6 |
MED Community Fair Values
Create NarrativeSee what others think this stock is worth. Follow their fair value or set your own to get alerts.
Mediplantex National Pharmaceutical Joint Stock Company Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | ₫28,600.00 |
| 52 Week High | ₫28,600.00 |
| 52 Week Low | ₫22,200.00 |
| Beta | 0.11 |
| 1 Month Change | 14.40% |
| 3 Month Change | n/a |
| 1 Year Change | 2.88% |
| 3 Year Change | 18.67% |
| 5 Year Change | -25.71% |
| Change since IPO | -41.63% |
Recent News & Updates
Recent updates
Shareholder Returns
| MED | VN Pharmaceuticals | VN Market | |
|---|---|---|---|
| 7D | 7.9% | 0.7% | 2.3% |
| 1Y | 2.9% | 7.5% | 4.6% |
Return vs Industry: MED underperformed the VN Pharmaceuticals industry which returned 9% over the past year.
Return vs Market: MED underperformed the VN Market which returned 4.5% over the past year.
Price Volatility
| MED volatility | |
|---|---|
| MED Average Weekly Movement | n/a |
| Pharmaceuticals Industry Average Movement | 5.0% |
| Market Average Movement | 6.1% |
| 10% most volatile stocks in VN Market | 8.4% |
| 10% least volatile stocks in VN Market | 4.3% |
Stable Share Price: MED's share price has been volatile over the past 3 months compared to the VN market.
Volatility Over Time: Insufficient data to determine MED's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1958 | n/a | Thanh Mai | www.mediplantex.com |
Mediplantex National Pharmaceutical Joint Stock Company produces and trades in pharmaceutical products in Vietnam and internationally. The company offers pharmaceutical products in various categories, including drugs from herbals; analgesics, corticosteroid, and anti-inflammatory drugs; antibiotics; cerebral circulation, heart, and lung drugs; anti-malarial, demostasis, gout, diabetes, allergies, and osteoarthritis drugs; acid amin, vitamins, and minerals; and other products. It also provides pharmaceutical chemicals and medicinal herbs; and extracting and semi synthetic materials, such as essential oils.
Mediplantex National Pharmaceutical Joint Stock Company Fundamentals Summary
| MED fundamental statistics | |
|---|---|
| Market cap | ₫354.93b |
| Earnings (TTM) | ₫15.18b |
| Revenue (TTM) | ₫443.14b |
Is MED overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| MED income statement (TTM) | |
|---|---|
| Revenue | ₫443.14b |
| Cost of Revenue | ₫350.65b |
| Gross Profit | ₫92.48b |
| Other Expenses | ₫77.30b |
| Earnings | ₫15.18b |
Last Reported Earnings
Dec 31, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 1.22k |
| Gross Margin | 20.87% |
| Net Profit Margin | 3.43% |
| Debt/Equity Ratio | 8.4% |
How did MED perform over the long term?
See historical performance and comparisonDividends
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/06/18 03:21 |
| End of Day Share Price | 2025/06/18 00:00 |
| Earnings | 2024/12/31 |
| Annual Earnings | 2024/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Mediplantex National Pharmaceutical Joint Stock Company is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.